Colourful i-Base graphic. The main text reads: First new HSV drug class in years will be submitted for FDA approval this quarter. In the top left is i-Base’s website address: I hyphen base dot info. A smaller rectangle in the bottom right, reads: HIV news. 2026. CROI 2026, is in the top right corner with CROI’s logo, a colourful illustration of the HIV virus. At the bottom, text reads, Denver, Colorado. February 22nd to 25th. Large colourful virus illustrations are faintly seen in the background of the image. The colours used in the image are pale blue, pale green, orange, dark blue, purple, turquoise, yellow, white, pink, green and black.

Pritelivir active against drug-resistant #herpes in phase 3 study:

i-base.info/htb/53453

The US FDA has given #pritelivir Breakthrough Indication designation, with submission of a New Drug Indication expected by the end of March.

#CROI2026 #HIV #HSV #CureHerpes #IDsky #HIVsky #GUMsky

Herpes-Infektion: Pritelivir – Arzneistoff mit neuem Wirkprinzip Pritelivir hat in einer Phase-III-Studie überzeugen können. Die Studie untersuchte Wirksamkeit und Sicherheit des Wirkstoffs bei immungeschw&auml...

Der First-in-Class-Wirkstoff #Pritelivir hat in einer Phase-III-Studie überzeugen können. Die Studie untersuchte Wirksamkeit und Sicherheit von Pritelivir bei immungeschwächten Patienten mit refraktären Herpes-simplex-Virus (HSV)-Infektionen.